59.02
-0.38
(-0.64%)
At close: 9:16:22 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 28 | 22 | 36 | 38 |
| Avg. Estimate | 377.7M | 347.4M | 1.33B | 1.7B |
| Low Estimate | 355.52M | 305.5M | 1.3B | 1.48B |
| High Estimate | 392M | 438M | 1.41B | 2.48B |
| Year Ago Sales | 302.57M | 263.34M | 2.29B | 1.33B |
| Sales Growth (year/est) | 24.83% | 31.92% | -42.01% | 28.12% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| E0P.F | -- | -- | -- | -- |
| S&P 500 | 9.39% | 11.29% | 14.06% | 13.54% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 1/22/2025 |
| Downgrade | Truist Securities: Buy to Hold | 1/16/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/14/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/8/2025 |
| Maintains | Citigroup: Neutral to Neutral | 1/8/2025 |
| Upgrade | OTR Global: Negative to Mixed | 12/20/2024 |